The predictive value of PD-L1 expression has been confirmed in non-small cell lung cancer and gastric cancer, and PD-L1 detection with immunohistochemical staining has been widely used to guide the application of ICIs treatment in these tumours (110, 111). This evidence concerns the gene CD274 and gastric cancer.